Forouzanfar Fatemeh, Butler Alexandra E, Banach Maciej, Barreto George E, Sahbekar Amirhossein
Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Life Sciences Research Division, Anti-Doping Laboratory Qatar, Sports City Road, Doha, Qatar.
Pharmacol Res. 2018 Aug;134:134-144. doi: 10.1016/j.phrs.2018.06.020. Epub 2018 Jun 20.
Heat shock proteins (HSP or stress proteins) are intracellular molecules that participate in physiological cell metabolism and growth, although they are known to be involved in many stress conditions. Statins inhibit the action of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA), which is important in the synthesis of cholesterol and essential isoprenoid intermediates, thereby lowering circulating low-density lipoprotein cholesterol (LDL), a major risk factor for cardiovascular disease (CVD). This review provides new insights into the mechanisms of action of statins in the regulation of HSPs. A better understanding of this involvement can help in development of new and more effective treatment strategies for CVD.
热休克蛋白(HSP或应激蛋白)是细胞内分子,参与细胞的生理代谢和生长,尽管已知它们也参与多种应激状况。他汀类药物抑制3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA)的作用,该酶在胆固醇和必需类异戊二烯中间体的合成中起重要作用,从而降低循环中的低密度脂蛋白胆固醇(LDL),而LDL是心血管疾病(CVD)的主要危险因素。本综述为他汀类药物调节热休克蛋白的作用机制提供了新见解。更好地理解这种关联有助于开发针对心血管疾病的更新、更有效的治疗策略。